Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

128.96 +0.41 (+0.32%)
Official Closing Price Updated: 8:00 PM EDT, Apr 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about State Street SPDR S&P Biotech ETF

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
News headline image
Small Cap Biotech Stocks Are Trending Well ↗
Despite a little weakness last week, small cap biotechs are trending well for traders. For investors entering the trade on July 5 all of our. focus stocks are up except ChemoCentryx. 
Via Talk Markets
News headline image
CNBC's Final Trades: Biotech, CVS Health, Walt Disney And This Stock That Could Benefit From Taiwan Semiconductor's Earnings Release ↗
On CNBC’s “Halftime Report Final Trades,” Bryn Talkington of Requisite Capital Management chose SPDR S&P Biotech ETF (NYSE: XBI). 
Via Benzinga
News headline image
CNBC Fast Money Favorites: AMD, CVS, And One Of The Worst Performers In The S&P 500 Today ↗
CNBC’s "Fast Money: Halftime Report" delivers market-moving news to investors. The commentary delivered by hosts of the show often moves the stocks mentioned. The... 
Via Benzinga
News headline image
5 ETFs Riding High On The Biotech Comeback ↗
The high-growth biotech segment has borne the maximum brunt of the broader market sell-off. 
Via Talk Markets
News headline image
Time For A Pause Or Mild Pullback? ↗
The stock market has had a nice little rally over the past week. It still needs to clear some upside to see that defined higher highs and higher lows, but let’s not be greedy here. 
Via Talk Markets
News headline image
7 Best Biotech Stocks to Buy in July 2022 ↗
The best biotech stocks to buy are a lot like the best computer stocks 40 years ago; the biggest similarity is how hard they are to predict. 
Via InvestorPlace
News headline image
3 Biotech Stocks to Sell Now ↗
These biotech stocks remain vulnerable to more downside. Their charts remain broken and resistance looms ominously overhead. 
Via InvestorPlace
News headline image
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates ↗
The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment. 
Via Benzinga
News headline image
3 Stocks to Sell Now ↗
Equities suffer from the highest inflation readings of a generation. Here's a trio of S&P 500 stocks to sell before things get worse. 
Via InvestorPlace
News headline image
7 Biotech Stocks With Key Catalysts Coming in July ↗
Biotech stocks have had a rocky few months, but many are on the mend. These picks should provide investors both flexibility and growth. 
Via InvestorPlace
News headline image
U.S. Weekly FundFlows Insight Report: Sector-Energy Funds Report $1.3 Billion in Outflows, Fourth Largest on Record ↗
During fund-flows week ended June 22, 2022, investors were overall net sellers of fund assets (including both conventional funds and ETFs) for the second straight week, withdrawing a net $20.1... 
Via Talk Markets
News headline image
3 Beaten-Down ETFs to Buy Before They Rebound ↗
The charts are improving for these fallen angels, and that makes them all top ETFs to buy for the back half of the year. 
Via InvestorPlace
News headline image
“Should’ve Been Me” Stock Market (And Sentiment Results) ↗
In this week’s AAII Sentiment Survey result, bullish percent ticked down to 18.2% this week from 19.4% last week. 
Via Talk Markets
News headline image
Option Bears Reloading as Bulls Feeling Spry ↗
As the bulls have their moment, the bears are adding bearish options positions and rolling up into the strength. 
Via Talk Markets
News headline image
Stock Drop On June 16, But A Rally May Be Coming After Options Expiration ↗
Another miserable day for stocks, with the S&P 500 dropping 3.25% 
Via Talk Markets
News headline image
Do Crispr And Vertex Have A 'Functional Cure' For Blood Diseases? ↗
Crispr and Vertex tested their gene-edited drug in two blood diseases. 
Via Investor's Business Daily
News headline image
“Chip Shot” Stock Market (And Sentiment Results) ↗
Chips are the key to the economy/inflation moving forward. They are also the key to one of our major new positions in an auto-supplier 
Via Talk Markets
News headline image
3 Biotech Stocks to Buy Before They Boom ↗
It could be a “never-before, never-after opportunity” to buy into these biotech stocks that trade at very attractive valuations. 
Via InvestorPlace
News headline image
Again, Buy ‘Em ↗
Today we discuss again why it’s time to start adding back risk. We cover the major breadth thrusts that fired, some great monthly charts, and more. 
Via Talk Markets
News headline image
As COVID Subsidies, Here are 8 Infectious Diseases That Could Emerge As Potent Threats ↗
The COVID-19 pandemic that emerged in early 2020 doesn't seem to have run its course. Daily average cases, though have declined notably, stood at 110,084 in the U.S. as of Thursday, according to data... 
Via Benzinga
News headline image
PreMarket Prep: Looking For Biotech Bargains With This Wedbush Analyst ↗
Biotechnology is one sector that peaked ahead of the S&P 500 index. While the S&P 500 index did not peak until January, the SPDR Biotech (NYSE: XBI) peaked in February 2021 and is now 60% lower than... 
Via Benzinga
News headline image
This Biotech Looks Good With Increased M&A activity ↗
Fierce Biotech backs this up: “Biopharmas have $1.7 trillion to spend on deals this year, and big players like Novartis, Pfizer and Merck & Co. have made it pretty clear they’re on the hunt for... 
Via Talk Markets
News headline image
The “Mystery Liquidator Revealed” Stock Market (And Sentiment Results) ↗
In this week’s AAII Sentiment Survey result, Bullish Percent ticked up a hair to 26% this week from 24.3% last week. Bearish Percent rose to 50.4% from 49%. 
Via Talk Markets
News headline image
Large Cap Biopharmaceuticals: Provide Growth, Value And Yield ↗
Now that all major biopharmaceutical earnings are in, we can review the financial metrics and see if our portfolio needs re-balancing. 
Via Talk Markets
News headline image
When Will The Stock Market Stop Falling? ↗
Stocks have fallen dramatically just this past week, is a bottom near? 
Via Talk Markets
News headline image
Stocks Tank On May 11 With No Bottom In Sight ↗
Despite the sharp decline, the VIX finished down on the day at 32.5. It tells us there was “real” selling in the market today. 
Via Talk Markets
News headline image
7 Biotech Stocks With Key Catalysts for May ↗
The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns. 
Via InvestorPlace
News headline image
Should Biotech Be On The Critical List? ↗
The risk-off market has played havoc with the biotechs where the fundamentals have not changed as much as the valuation. 
Via Talk Markets
News headline image
“Threading The Needle” Stock Market (And Sentiment Results) ↗
Two weeks ago AAII sentiment survey dropped to a 30 year low at 15.8% bullish. Last week it ticked up modestly to 16.4%. 
Via Talk Markets
News headline image
7 Monster Stock Market Predictions For The Week Of April 25 ↗
The week ending April 22 was brutal. The S&P 500 fell by nearly 2.75%, but things were much worse than that. Powell unleashed hell when he noted that a 50 bps rate hike was on the table for the FOMC... 
Via Talk Markets
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.